Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae

The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex β-lactamase backgrounds. Relebactam is a β-lactamase inhibitor that possesses the diazabicyclooctane core, as in avibactam; however, the R1 side chain...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Papp-Wallace, Krisztina M., Barnes, Melissa D., Alsop, Jim, Taracila, Magdalena A., Bethel, Christopher R., Becka, Scott A., van Duin, David, Kreiswirth, Barry N., Kaye, Keith S., Bonomo, Robert A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2018
Onderwerpen:
Mechanisms of Resistance
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5971601/
https://ncbi.nlm.nih.gov/pubmed/29610205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00174-18
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items